{
  "id": 14971087,
  "title": "Oxford spin-out OMass Therapeutics lands €275 million to bring novel small-molecule therapies closer to patients",
  "url": "https://urgent.news/2026/10/16/oxford-spin-out-omass-therapeutics-lands-275-million-to-bring-novel",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-16T13:59:14.000Z",
  "source": {
    "name": "EU-Startups",
    "slug": "eu-startups",
    "url": "https://www.eu-startups.com/2026/10/oxford-spin-out-omass-therapeutics-lands-e275-million-to-bring-novel-small-molecule-therapies-closer-to-patients/"
  },
  "original_language": "en",
  "account": null,
  "summary": "OMass Therapeutics, a UK BioTech company developing small molecule therapeutics against highly validated target ecosystems, announced an oversubscribed €275 million (£230 million) Series C round. The round was co-led by new investors Bain Capital Life Sciences, Forbion and Novo Holdings, with additional participation from Janus Henderson Investors, SV Health Investors and Jefferson Life Sciences.…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}